Saturday, November 22, 2008 - 8:46AM EST

Review Articles

41. Historical review of carbamazepine for the treatment of bipolar disorder.

Author
Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM;
Institution
School of Pharmacy, University of Missouri, Kansas City, Missouri, USA. stoners@umkc.edu
Journal
Pharmacotherapy. 2007 Jan;27(1):68-88.
Abstract URL
Click here to view abstract

42. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Author
Post RM; Ketter TA; Uhde T; Ballenger JC;
Institution
Bipolar Collaborative Network, Chevy Chase, Maryland, USA.
Journal
CNS Drugs. 2007;21(1):47-71.
Abstract URL
Click here to view abstract

43. Adaptive strategies for treating childhood mania.

Author
Dawson R; Lavori PW; Luby JL; Ryan ND; Geller B;
Institution
Frontier Science Technology and Research Foundation, Boston, Massachusetts 02215, USA. Dawson@fstrf.dfci.harvard.edu
Journal
Biol Psychiatry. 2007 Mar 15;61(6):758-64. Epub 2006 Dec 12.
Abstract URL
Click here to view abstract

44. Zonisamide for bipolar depression.

Author
Wilson MS; Findling RL;
Institution
Case Western Reserve University/University Hospitals Case Medical Center, Division of Child & Adolescent Psychiatry, Department of Psychiatry, 11100 Euclid Ave, Cleveland, OH 44106-5080, USA.
Journal
Expert Opin Pharmacother. 2007 Jan;8(1):111-3.
Abstract URL
Click here to view abstract

45. Bipolar depression: a review of randomised clinical trials.

Author
Goodnick PJ;
Institution
Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, POB 147, 252 CR 601, Belle Mead, NJ 08502, USA. pgoodnick@aol.com
Journal
Expert Opin Pharmacother. 2007 Jan;8(1):13-21.
Abstract URL
Click here to view abstract

46. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.

Author
Post RM; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck PE Jr; Leverich GS; Kupka R; Nolen WA; Grunze H;
Institution
Penn State College of Medicine, Hershey, PA, USA. robert.post@speakeasy.net
Journal
Curr Psychiatry Rep. 2006 Dec;8(6):489-97.
Abstract URL
Click here to view abstract

47. Bipolar II disorder: current and future treatment options.

Author
El-Mallakh R; Weisler RH; Townsend MH; Ginsberg LD;
Institution
Dept. of Psychiatry, University of Louisville School of Medicine, Louisville, KY 40202, USA. rselma01@louisville.edu
Journal
Ann Clin Psychiatry. 2006 Oct-Dec;18(4):259-66.
Abstract URL
Click here to view abstract

48. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.

Author
Singh JB; Zarate CA Jr;
Institution
Mood and Anxiety Disorders Research Program, National Institute of Mental Health, 10 Center Drive, Bethesda, MD 20892, USA.
Journal
Bipolar Disord. 2006 Dec;8(6):696-709.
Abstract URL
Click here to view abstract

49. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

Author
Smith LA; Cornelius V; Warnock A; Tacchi MJ; Taylor D;
Institution
Medical Research Matters, Eynsham, UK.
Journal
Acta Psychiatr Scand. 2007 Jan;115(1):12-20.
Abstract URL
Click here to view abstract

50. Oxcarbazepine in bipolar disorder: a critical review of the literature.

Author
Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S;
Institution
Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy. mariannamazza@hotmail.com
Journal
Expert Opin Pharmacother. 2007 Apr;8(5):649-56.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7